Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Radar tech maps pelvic floor movement to improve incontinence care

NCT ID NCT07608146

Knowledge-focused Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will use millimeter-wave radar to measure how the pelvic floor muscles move in 2,000 women, both healthy and those with stress urinary incontinence. The goal is to create a large database of normal movement patterns and build a standard assessment system. This is an observational study that does not test a new treatment, but aims to improve future diagnosis and care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Based on BMI values, it is planned to recruit 200 participants with BMI \< 18.5 kg/m², 600 participants with BMI between 18.5 and 24 kg/m², and 200 participants with BMI \> 24 kg/m². A total of 1,000 study subjects will be recruited for healhty group and 1,000 for SUI group, amounting to 2,000 participants in total.

Ages

18 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female, aged between 18 and 60 years old * Signed the informed consent form * Healthy group demonstrated no pelvic floor dysfunction * SUI group had stress urinary incontinence symptom Exclusion Criteria: * Participants with cognitive behavioral disorders, mental illnesses, or those who are unable to cooperate * Participants who cannot demonstrate correct pelvic floor muscle contraction * Participants who were within 1 year postpartum * Participants who were post hysterectomy * Participants who had pain during internal exam or refused to have internal exam * SUI group who had pelvic organ prolapse symptoms or whose POP-Q lowest level reached or exceeded the hymenal ring * SUI group had urgency urinary incontinence symptoms * SUI group had chronic constipation symptoms

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stress urinary incontinence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stress urinary incontinence (SUI)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    20 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Anhui Provincial Hospital

    Hefei, Anhui, 23001, China

  • Chengdu Fifth People's Hospital

    Chengdu, Sichuan, 611130, China

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, 550002, China

  • Maternal and Child Health Hospital of Linxia Hui Autonomous Prefecture

    Linxia, Gansu, 731100, China

  • Mudanjiang Maternal and Child Health Hospital

    Mudanjiang, Heilongjiang, 157000, China

  • Ningbo Ninth Hospital

    Ningbo, Zhejiang, 315020, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100730, China

  • People's Hospital of Zhengzhou

    Zhengzhou, Henan, 450000, China

  • Shanghai Sixth People's Hospital

    Shanghai, Shanghai Municipality, 200233, China

  • Shanghai Tenth People's Hospital

    Shanghai, Shanghai Municipality, 200072, China

  • Shanxi Maternal and Child Health Hospital

    Taiyuan, Shanxi, 030013, China

  • Tangshan Maternal and Child Health Care Hospital

    Tangshan, Hebei, 063000, China

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, 830054, China

  • The First People's Hospital of Qinzhou

    Qinzhou, Guangxi, 535000, China

  • The Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450000, China

  • The Second Hospital of Tianjin Medical University

    Tianjin, Tianjin Municipality, 300211, China

  • Yan'an Hospital Affiliated to Kunming Medical University

    Kunming, Yunnan, 650032, China

  • Zaozhuang Municipal Hospital

    Zaozhuang, Shandong, 277102, China

  • Zunyi Maternal and Child Health Hospital

    Zunyi, Guizhou, 563000, China

  • the First Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, 210029, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.